Pharmaceutical Research and Manufacturers of America, formerly known as the Pharmaceutical Manufacturers Association, is a trade group representing companies in the pharmaceutical industry in the United States. Founded in 1958, PhRMA lobbies on behalf of pharmaceutical companies. PhRMA is headquartered in Washington, D.C.
Ranbaxy Laboratories Limited was an Indian multinational pharmaceutical company that was incorporated in India in 1961 and remained an entity until 2014. The company went public in 1973. Ownership of Ranbaxy changed twice over the course of its history.
AstraZeneca plc (AZ) is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent.
The Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme (PIC/S) are two international instruments between countries and pharmaceutical inspection authorities. The PIC/S is meant as an instrument to improve co-operation in the field of Good Manufacturing Practices between regulatory authorities and the pharmaceutical industry.
The Japan Pharmaceutical Manufacturers Association (JPMA) is the organization representing the research-based pharmaceutical industry operating in Japan.
Network for Excellence in Health Innovation (NEHI), formerly New England Healthcare Institute is a member-based, non-partisan research and policy organization.
Severin Anton Schwan is an Austrian business executive. He is the current chairman of the board and former CEO (2008–2023) of the Roche Group.
Inovalon is an American technology company that provides cloud-based tools for healthcare.
The International Hospital Federation (IHF) is an independent, not-for-profit, non-governmental organization based in Bernex, Switzerland. The IHF is a global membership association for hospital management that assists leaders of healthcare organizations and facilities in improving the standard, quality, and level of service delivery to improve the healthcare outcomes of people all over the world. The IHF provides a platform for the global healthcare community to share knowledge, ideas, and experiences, as well as identify international partnerships and collaboration opportunities. The IHF also represents the voice of hospitals and health systems on the global stage in initiatives, research, and joint statements with other global institutions and NGOs. Furthermore, the IHF established the Geneva Sustainability Centre in 2022 in response to the need for hospitals and healthcare services to address climate change.
The life sciences industry in Switzerland directly and indirectly employs about 135,000 people. It contributes 5.7% of the gross domestic product of Switzerland and 30% of the country's exports. In 2017 about 30% of Swiss exports were chemical products. In the same year Switzerland was the second largest exporter of packaged medicine in the world, with about 11% of the global total, worth $36.5 billion.
The Global Health Innovative Technology Fund, headquartered in Japan, is an international public-private partnership between the Government of Japan, 16 pharmaceutical and diagnostics companies, the Bill & Melinda Gates Foundation, the Wellcome Trust and United Nations Development Programme. It funds scientific research and development for anti-infectives and diagnostics for diseases that primarily affect the developing world. Bill Gates has noted that "GHIT draws on the immense innovation capacity of Japan’s pharmaceutical companies, universities and research institutions to accelerate the creation of new vaccines, drugs and diagnostic tools for global health." Margaret Chan, former Director-General of the World Health Organization, said: "The GHIT Fund has stepped in to provide that incentive in a pioneering model of partnership that brings Japanese innovation, investment and leadership to the global fight against infectious disease."
Olivier Brandicourt is a French business executive and physician, and the former chief executive officer of Sanofi.
The Pharma Documentation Ring (P-D-R), founded in 1958, is a think tank of information and knowledge-management professionals representing major research-based pharmaceutical companies. The association has four aims:
Stefan Oschmann is a German businessman. He was the CEO of pharma group Merck.
The Verband Forschender Arzneimittelhersteller (vfa) or Association of Research-Based Pharmaceutical Companies, is the trade group of 43 pharmaceutical companies in Germany which are global players, representing more than two-thirds of the German pharmaceutical market, with nearly 80,000 employees in Germany.
Albert Bourla is a Greek-American veterinarian and businessman known for serving as the chairman and chief executive officer of the pharmaceutical company Pfizer. He joined the company in 1993 and has held several executive roles across Pfizer's divisions. Prior to becoming chief executive officer, Bourla was chief operating officer.
Dr. Thomas Schinecker is an Austrian-German pharmaceutical executive and the chief executive officer of the Roche Group since March 2023. He succeeded Severin Schwan, who was elected chairman of the board of directors of the Roche Group.
Gisela Maame Abbam FRSA is a Ghanaian-British businesswoman working in both the private and public sector who has focused on the healthcare industry. She is the first black Chair of the General Pharmaceutical Council, and is the first black chair of the British Science Association. She is a board member of the Bar Standards Board, a commissioner on the National Preparedness Commission as well as a Senior director at Revvity. She is a former Global Executive Director at General Electric and an advisor at National Institute for Health and Care Excellence.
